As the Covid-19 pandemic continues to grip the world, some pharma companies are racing toward a vaccine at a record pace, but are their methods up to par? Plus, the tit-for-tat tension between the United States and China is heating up, and we’re here to catch you up on the developments. And with global turmoil rattling markets, investors are flocking to ‘safe-haven’ assets.